Global Sepsis Diagnostics Market Overview
Sepsis is a kind of severe life-threatening organ dysfunction that emerges due to the overwhelming response of the body to infection harming its own tissues and organs. Sepsis arises due to the body’s reaction to bacterial, fungal, parasitic, or viral infection, which may lead to multiple organ failure, septic shock, and death. According to W.H.O., sepsis kills 11 million people each year, many of them children. And the most common causes of sepsis-related deaths were diarrhoeal diseases, lower respiratory infections, and neonatal disorders among children. The high prevalence and increasing mortality rate due to sepsis are largely driving the demand for sepsis diagnostics products and solutions. The Sepsis Diagnostics Market accounted for US$ 530.5 million in 2020 and is estimated to be US$ 1070 million by 2029 and is anticipated to register a CAGR of 8.1%.
Impact of Covid-19 pandemic on market
Due to the outbreak of COVID-19, biopharmaceutical innovators are at the forefront of the human response. A huge number of foremost biotech companies are in the midst of a race to explore the Sars-Cov-2 genome and prepare a viable vaccine for the same. With multiple aspirants in the trial, the public and private sectors are expected to work in unison in the coming years, until a vaccine is developed for Covid-19. The report will estimate Covid19 as a significant market contributor.
Global Sepsis Diagnostics Market Dynamics
The high prevalence of sepsis and high incidence of hospital-acquired infections are expected to be the significant factor driving the sepsis diagnostics market across the globe. The government initiatives and funding for research activities are projected to boost the sepsis diagnostics market growth by the end of the forecast period.
The rising health awareness and healthcare expenditures among the people is anticipated to boost the global sepsis diagnostics market growth in the forecast period. According to a W.H.O. report, 1 in 5 deaths is caused due to sepsis across the globe. The alarming fact and figures of various health organizations towards sepsis are likely to aware people of different regions. The aging population and health freaks are likely to demand sepsis diagnostics solutions which are expected to be the major factor driving the growth of the global sepsis diagnostics market. Moreover, the major player of the sepsis diagnostics market has an opportunity to strengthen their presence in developing economies and acquiring considerable market share through partnerships with local players.
Restraints :
The knowledge gap and minimal government efforts in low and middle-income countries may hamper the growth of the global sepsis diagnostics market. Also, limited skilled staff and lack of established health systems in developing countries are hindering the growth of the sepsis diagnostics market
Global Sepsis Diagnostics Market Segmentation
The global sepsis diagnostics market is segmented based on the product, technology, pathogen, end-users, and region.
On the basis of product type, the global sepsis diagnostics market is segmented into instruments, blood culture media, assay kits, and reagents and software. On the basis of technology, the market is segmented in microbiology, molecular diagnostics, immunoassays, biomarkers, and others. On the basis of pathogens, the global sepsis diagnostics market is segmented into bacterial, fungal, and others. On the basis of end-user, the target market is segmented into pathology laboratories, hospitals, research laboratories & academic institutes, and others.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
In the region, the global sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is well established in the sepsis diagnostics market, due to the presence of a developed healthcare system and technological advancements in the region. The high adoption rate for new sepsis diagnostics techniques among medical professionals is one of the factors driving the North American sepsis diagnostics market. Asia Pacific region is projected to grow with a high growth rate in the global sepsis diagnostics market by the end of the forecast period.
|
Attribute |
Details |
|
The base year for estimation |
2020 |
|
Forecast period |
2021 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Product – Instruments, Blood Culture Media, Assay Kits & Reagents and Software By Technology – Microbiology, Molecular Diagnostics, Immunoassays, Biomarkers and Others By Pathogen – Bacterial, Fungal and Others By End Users – Pathology Laboratories, Hospitals, Research Laboratories & Academic Institutes and Others |
|
Regional Scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2029. For the purpose of this study, has segmented the global sepsis diagnostics market report based on the product, technology, pathogen, end-users, and region.
Global Sepsis Diagnostics Market, By Product Type:
- Instruments
- Blood Culture Media
- Assay Kits and Reagents
- Software
Global Sepsis Diagnostics Market, By Technology Type:
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Biomarkers
- Others
Global Sepsis Diagnostics Market, By Pathogen Type:
- Bacterial
- Fungal
- Others
Global Sepsis Diagnostics Market, By End Users Type:
- Pathology Laboratories
- Hospitals
- Research Laboratories & Academic Institutes
- Others
Global Sepsis Diagnostics Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Sepsis Diagnostics Market Key Players
The key players operating in the global sepsis diagnostics market include Abbott Laboratories, Becton, Dickinson and Company, Cepheid Inc., Luminex Corporation, T2 Biosystems, Inc., Thermo Fisher Scientific, Inc., bioMérieux SA, Bruker Corporation, Roche Diagnostics Limited, and other players. The major player in the sepsis diagnostics market is focusing on the research and development of new products and adopting new growth strategies. The players involved in the sepsis diagnostics market investing deliberately to build their distribution channel to serve developing markets. Some companies also adopting new technologies through merger acquisitions and partnerships to strengthen their product portfolio.
Global Sepsis Diagnostics Market Company Profile
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Becton, Dickinson and Company,
- bioMérieux SA
- Bruker Corporation
- Cepheid Inc.
- EKF Diagnostics
- Luminex Corporation
- Roche Diagnostics Limited
- T2 Biosystems, Inc.
- Thermo Fisher Scientific, Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global Sepsis Diagnostics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Sepsis Diagnostics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Pathogen
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Sepsis Diagnostics Market, By Product Type, 2021 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2021 – 2029
- Y-o-Y Growth Analysis (%), 2021 – 2029
- Segment Trends
- Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Blood Culture Media
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Assay Kits and Reagents
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Software
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Overview
- Global Sepsis Diagnostics Market, By Technology, 2021 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2021 – 2029
- Y-o-Y Growth Analysis (%), 2021 – 2029
- Segment Trends
- Microbiology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Molecular Diagnostics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Immunoassays
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Biomarkers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Other
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Overview
- Global Sepsis Diagnostics Market, By Pathogen, 2021 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2021 – 2029
- Y-o-Y Growth Analysis (%), 2021 – 2029
- Segment Trends
- Bacterial
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Fungal
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Other
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Overview
- Global Sepsis Diagnostics Market, By End-user, 2021 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2021 – 2029
- Y-o-Y Growth Analysis (%), 2021 – 2029
- Segment Trends
- Pathology Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Research Laboratories & Academic Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2021 – 2029
- Overview
- Global Sepsis Diagnostics Market, By Region, 2021 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2021 – 2029
- Y-o-Y Growth Analysis (%), 2021 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product Type, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Pathogen, 2021 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2021 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product Type, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Pathogen, 2021 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2021 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product Type, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Pathogen, 2021 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2021 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product Type, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Pathogen, 2021 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2021 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product Type, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Pathogen, 2021 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2021 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2021 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott Laboratories
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
-
- Becton, Dickinson and Company,
- bioMérieux SA
- Bruker Corporation
- Cepheid Inc.
- EKF Diagnostics
- Luminex Corporation
- Roche Diagnostics Limited
- T2 Biosystems, Inc.
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Network Sepsis Diagnostics Market report segments based on instruments, blood culture media, assay kits and reagents, and software.
As more network Sepsis Diagnosticses are included in spreading awareness about the life-threatening disease condition which is anticipated to facilitate market growth.
North America market dominates the Network Sepsis Diagnostics market.
The leading players operating in the Network Sepsis Diagnostics Market include Abbott Laboratories, Becton, Dickinson and Company, Cepheid Inc., Luminex Corporation, T2 Biosystems, Inc., Thermo Fisher Scientific, Inc., bioMérieux SA, Bruker Corporation, Roche Diagnostics Limited, and other players.